Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis

Iron Chelation Therapy with Deferasirox in the Management of Iron Overload in Primary Myelofibrosis

Deferasirox (DSX) is the principal option currently available for iron-chelation-therapy (ICT), principally in the management of myelodysplastic syndromes (MDS), while in primary myelofibrosis (PMF) the expertise is limited. We analyzed our experience in 10 PMF with transfusion-dependent anemia, tre...

Full description

Bibliographic Details
Main Authors: Elli, Elena Maria, Belotti, Angelo, Aroldi, Andrea, Parma, Matteo, Pioltelli, Pietro, Pogliani, Enrico Maria
Format: Online
Language:English
Published: Università Cattolica del Sacro Cuore 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063602/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063602/

Similar Items